Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism

Transplantation

Volumn 82, Issue 5, 2006, Pages 675-680

  Szwarc, Ilan ^a,b   Argilés, Àngel ^a,b,c   Garrigue, Valérie ^a   Delmas, Sylvie ^a   Chong, Guillaume ^a   Deleuze, Sébastien ^a   Mourad, Georges ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^c Néphrologie   (France)

Author keywords

Calcimimetic; Hypercalcemia; Hyperparathyroidism; Kidney transplantation

Indexed keywords

CALCIUM; CINACALCET; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MALE; PARATHYROID HORMONE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; RANK SUM TEST; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; VOMITING;

CALCIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHATES; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; SAFETY;

EID: 33748680484     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000232452.80018.ad     Document Type: Article

References (34)

1. Torres A, Rodriguez AP, Concepcion MT, et al. Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 1998; 13(Suppl 3): 94.
2. Botha JF, Botha JR. Parathyroid function after successful renal transplantation. S Afr J Surg 1997; 35: 113.
3. Evenepoel P, Claes K, Kuypers D, et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004; 19: 1281.
4. Babarykin D, Adamsone I, Amerika D, et al. Disorders of calcium metabolism at various times after renal transplantation. Ann Transplant 1999; 4: 46.
5. Massari PU. Disorders of bone and mineral metabolism after renal transplantation. Kidney Int 1997; 52: 1412.
6. Evenepoel P, Claes K, Kuypers D, et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 2005; 20: 1714.
7. Coburn JW, Elangovan L, Goodman WG, Frazao JM. Calcium-sensing receptor and calcimimetic agents. Kidney Int 1999; 73: S52.
8. Pearce SH, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 1995; 96: 2683.
9. Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297.
10. Brown EM, Hebert SC. Calcium-receptor-regulated parathyroid and renal function. Bone 1997; 20: 303.
11. Chattopadhyay N, Cheng I, Rogers K, et al. Identification and localization of extracellular Ca(2+)-sensing receptor in rat intestine. Am J Physiol 1998; 274: 122.
12. Silverberg SJ, Bone HG 3rd, Marriott TB, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997; 337: 1506.
13. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516.
14. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311.
15. Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315.
16. Bonarek H, Merville P, Bonarek M, et al. Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 1999; 56: 642.
17. Sperschneider H, Stein G. Bone disease after renal transplantation. Nephrol Dial Transplant 2003; 18: 874.
18. Heaf JG. Bone disease after renal transplantation. Transplantation 2003; 75: 315.
19. Traindl O, Langle F, Reading S, et al. Secondary hyperparathyroidism and acute tubular necrosis following renal transplantation. Nephrol Dial Transplant 1993; 8: 173.
20. Leapman SB, Vidne BA, Butt KM, et al. Nephrolithiasis and nephrocalcinosis after renal transplantation: a case report and review of the literature. J Urol 1976; 115: 129.
21. Schwarz A, Mengel M, Gwinner W, et al. Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int 2005; 67: 341.
22. Kurella M, Butterly DW, Smith SR. Post transplant erythrocytosis in hypercalcemic renal transplant recipients. Am J Transplant 2003; 3: 873.
23. McCarron DA, Rankin LI, Bennett WM, et al. Urinary calcium excretion at extremes of sodium intake in normal man. Am J Nephrol 1981; 1: 84.
24. Campese VM. Calcium, parathyroid hormone, and blood pressure. Am J Hypertens 1989; 2: 34.
25. Srinivas TR, Schold JD, Womer KL, et al. Improvement in Hypercalcemia with Cinacalcet after Kidney Transplantation. Clin J Am Soc Nephrol 2006; 1: 323.
26. Leonard N, Brown JH. Persistent and symptomatic post-transplant hyperparathyroidism: a dramatic response to cinacalcet. Nephrol Dial Transplant 2006; 21: 1736.
27. Shoback DM, Bilezikian JP, Turner SA, et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88: 5644.
28. Lindberg JS, Culleton B, Wong G, et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 2005; 16: 800.
29. Pfister MF, Lederer E, Forgo J, et al. Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem 1997; 272: 20125.
30. Saha HH, Salmela KT, Ahonen PJ, et al. Sequential changes in vitamin Dand calcium metabolism after successful renal transplantation. Scand J Urol Nephrol 1994; 28: 21.
31. Reinhardt W, Bartelworth H, Jockenhovel F, et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998; 13: 436.
32. Conigrave AD, Lok HC. Activation of renal calcium and water excretion by novel physiological and pharmacological activators of the calcium-sensing receptor. Clin Exp Pharmacol Physiol 2004; 31: 368.
33. Garcia A, Mazuecos A, Garcia T, et al. Effect of parathyroidectomy on renal graft function. Transplant Proc 2005; 37: 1459.
34. Rostaing L, Moreau-Gaudry X, Baron E, et al. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin Nephrol 1997; 47: 248.